Quality of life in inflammatory neuropathies : the IN-QoL

Autor: Draak, T.H., Faber, C.G., Merkies, I.S., Raaphorst, J., Schaik, I.N. van, Visser, M de
Přispěvatelé: MUMC+: MA AIOS Neurologie (9), RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, MUMC+: MA Med Staf Spec Neurologie (9), Klinische Neurowetenschappen
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Male
Visual Analog Scale
Minimal Clinically Important Difference
Paraproteinemias
1ST REVISION
0302 clinical medicine
Quality of life
HEALTH SURVEY SF-36
PARKINSONS-DISEASE
Surveys and Questionnaires
030212 general & internal medicine
PERIPHERAL-NERVE-SOCIETY
Guillain-Barre syndrome
NEUROLOGICAL-SOCIETIES
Peripheral Nervous System Diseases
Middle Aged
IMPAIRMENT
Disorders of movement Donders Center for Medical Neuroscience [Radboudumc 3]
humanities
DOENÇAS AUTOIMUNES
Psychiatry and Mental health
GUILLAIN-BARRE-SYNDROME
Female
JOINT TASK-FORCE
EUROPEAN-FEDERATION
Adult
medicine.medical_specialty
Adolescent
Visual analogue scale
Guillain-Barre Syndrome
03 medical and health sciences
Young Adult
ORDINAL SCALES
medicine
Humans
In patient
Aged
Rasch model
business.industry
Reproducibility of Results
Polyradiculoneuropathy
medicine.disease
Peripheral neuropathy
Polyradiculoneuropathy
Chronic Inflammatory Demyelinating

Physical therapy
Quality of Life
Surgery
Neurology (clinical)
business
Factor Analysis
Statistical

030217 neurology & neurosurgery
Multifocal motor neuropathy
Zdroj: Journal of Neurology Neurosurgery and Psychiatry, 89(3), 256-262. BMJ Publishing Group
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Journal of Neurology, Neurosurgery and Psychiatry, 89(3), 256. BMJ Publishing Group
Journal of Neurology, Neurosurgery, and Psychiatry, 89, 256-262
Journal of Neurology, Neurosurgery, and Psychiatry, 89, 3, pp. 256-262
ISSN: 0022-3050
DOI: 10.1136/jnnp-2017-316634
Popis: BackgroundNo consensus exists which quality of life (QoL) measure should be used in patients with inflammatory neuropathies. Moreover, most QoL measures are ordinal-based scales with their known deficiencies.ObjectivesTo establish a new disease-specific interval-based QoL questionnaire in inflammatory neuropathies (IN-QoL) using the Rasch model and evaluate its scientific properties (validity, reliability and responsiveness).Methods264 patients with inflammatory neuropathies completed six commonly used QoL questionnaires. The obtained data were stacked and subjected to Rasch analysis. Responsiveness was determined by using the concept of minimum clinically important differences related to varying individually obtained SEs (responsiveness definition: MCID-SE≥1.96 after 1-year follow-up compared with baseline).ResultsThe IN-QoL fulfilled all Rasch’s model requirements with high internal reliability values (patient separation index of 0.94), except being multidimensional. Additional factor analysis resulted in two (functional and mental) subsets that were unidimensional on their own. The IN-QoL showed good correlation with the EuroQol-health quality visual analogue scale (EQ-VAS) (Spearman’s rho 0.72). It demonstrated acceptable responsiveness in patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), as did the EQ-VAS. In patients with monoclonal gammopathy-related neuropathy and multifocal motor neuropathy, hardly any changes were seen over time.ConclusionThe IN-QoL questionnaire fulfils modern clinimetric requirements and correlates strongly with a patient’s self-assessment of their own quality of health, while also showing responsiveness in patients with GBS and CIDP. We propose using the IN-QoL and the EQ-VAS for assessing the QoL of patients with inflammatory neuropathies in future studies.
Databáze: OpenAIRE